, Volume 192, Issue 2, pp 193–206 | Cite as

Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol

  • Dawn M. Eagle
  • Miles R. A. Tufft
  • Hannah L. Goodchild
  • Trevor W. Robbins
Original Investigation



The stop-signal reaction time (SSRT) task measures inhibition of a response that has already been initiated, i.e. the ability to stop. ‘Impulsive’ human subjects, e.g. with attention deficit and hyperactivity disorder (ADHD), have longer SSRTs. Both SSRT and go-trial reaction time (GoRT) may be sensitive to drugs such as d-amphetamine, methylphenidate and modafinil, both in normal subjects and those with ADHD.


To investigate the effects of modafinil (3, 10, 30 and 100 mg/kg) and methylphenidate (0.3, 1.0 and 3.0 mg/kg) on SSRT task performance in the rat. To investigate the possible contribution of dopamine receptors in the action of these drugs using the mixed D1/D2 dopamine receptor antagonist cis-flupenthixol.


Modafinil significantly decreased SSRT with little effect on GoRT but only in rats with slow baseline SSRTs. Fast SSRTs were not changed by modafinil. Methylphenidate decreased GoRTs of all rats. However, methylphenidate had baseline-dependent effects on SSRT, decreasing SSRT in slow responders but increasing SSRT in fast responders. Cis-flupenthixol (0.01, 0.04 and 0.125 mg/kg) had no effects on SSRT but increased GoRT at higher doses. At the lowest dose (0.01 mg/kg), cis-flupenthixol failed to disrupt the SSRT-decreasing effects of either modafinil or methylphenidate, whereas at 0.04 mg/kg, the cis-flupenthixol-dependent increase in GoRT was antagonised by methylphenidate but not by modafinil.


This evidence supports a hypothesis that stop and go processes are under control of distinct neurochemical mechanisms.


Response inhibition SSRT d-amphetamine ADHD 



This study was supported by a Wellcome Trust Program Grant awarded to TWR, B. J. Everitt, A. C. Roberts and B. J. Sahakian, and completed within the University of Cambridge Behavioural and Clinical Neuroscience Institute, supported by a joint award from Medical Research Council and the Wellcome Trust. All procedures comply with the current laws of the UK.


  1. Arnsten AF, Dudley AG (2005) Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct 1:2PubMedCrossRefGoogle Scholar
  2. Arnsten AF, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377–1384PubMedCrossRefGoogle Scholar
  3. Aron AR, Dowson JH, Sahakian BJ, Robbins TW (2003) Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 54:1465–1468PubMedCrossRefGoogle Scholar
  4. Axelrod J, Mueller RA, Henry JP, Stephens PM (1970) Changes in enzymes involved in the biosynthesis and metabolism of noradrenaline and adrenaline after psychosocial stimulation. Nature 225:1059–1060PubMedCrossRefGoogle Scholar
  5. Barkley RA (1997) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121:65–94PubMedCrossRefGoogle Scholar
  6. Bastuji H, Jouvet M (1988) Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuro-psychopharmacol Biol Psychiatry 12:695–700CrossRefGoogle Scholar
  7. Bedard AC, Ickowicz A, Logan GD, Hogg-Johnson S, Schachar R, Tannock R (2003) Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. J Abnorm Child Psychol 31:315–327PubMedCrossRefGoogle Scholar
  8. Billiard M, Besset A, Montplaisir J, Laffont F, Goldenberg F, Weill JS, Lubin S (1994) Modafinil: a double-blind multicentric study. Sleep 17:S107–S112PubMedGoogle Scholar
  9. Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK (2005) Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? J Clin Exp Neuropsychol 27:278–298PubMedGoogle Scholar
  10. Bubser M, Fadel JR, Jackson LL, Meador-Woodruff JH, Jing D, Deutch AY (2005) Dopaminergic regulation of orexin neurons. Eur J Neurosci 21:2993–3001PubMedCrossRefGoogle Scholar
  11. Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M (1995) Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:1025–1032PubMedCrossRefGoogle Scholar
  12. Cantwell DP (1996) Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35:978–987PubMedCrossRefGoogle Scholar
  13. Cardinal RN, Aitken MRF (2001) Whisker, version 2.2, computer softwareGoogle Scholar
  14. Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R (2006) Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci 10:117–123PubMedCrossRefGoogle Scholar
  15. Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2006) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861–863PubMedCrossRefGoogle Scholar
  16. Dagan Y, Doljansky JT (2006) Cognitive performance during sustained wakefulness: a low dose of caffeine is equally effective as modafinil in alleviating the nocturnal decline. Chronobiol Int 23:973–983PubMedCrossRefGoogle Scholar
  17. DuPaul GJ, Barkley RA, McMurray MB (1994) Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry 33:894–903PubMedCrossRefGoogle Scholar
  18. Eagle DM, Robbins TW (2003a) Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci 117:1302–1317PubMedCrossRefGoogle Scholar
  19. Eagle DM, Robbins TW (2003b) Lesions of the medial prefrontal cortex or nucleus accumbens core do not impair inhibitory control in rats performing a stop-signal reaction time task. Behav Brain Res 146:131–144PubMedCrossRefGoogle Scholar
  20. Feola TW, de Wit H, Richards JB (2000) Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats. Behav Neurosci 114:838–848PubMedCrossRefGoogle Scholar
  21. Fillmore MT, Kelly TH, Martin CA (2005) Effects of d-amphetamine in human models of information processing and inhibitory control. Drug Alcohol Depend 77:151–159PubMedCrossRefGoogle Scholar
  22. Gauntlett-Gilbert J, Brown VJ (1998) Reaction time deficits and Parkinson’s disease. Neurosci Biobehav Rev 22:865–881PubMedCrossRefGoogle Scholar
  23. Gill M, Haerich P, Westcott K, Godenick KL, Tucker JA (2006) Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study. Acad Emerg Med 13:158–165PubMedCrossRefGoogle Scholar
  24. Hendley ED, Snyder SH, Fauley JJ, LaPidus JB (1972) Stereoselectivity of catecholamine uptake by brain synaptosomes: studies with ephedrine, methylphenidate and phenyl-2-piperidyl carbinol. J Pharmacol Exp Ther 183:103–116PubMedGoogle Scholar
  25. Howell DC (1997) Statistical methods for psychology, 4th edn. Duxbury, BelmontGoogle Scholar
  26. Ishizuka T, Sakamoto Y, Sakurai T, Yamatodani A (2003) Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci Lett 339:143–146PubMedCrossRefGoogle Scholar
  27. Krause J, la Fougere C, Krause KH, Ackenheil M, Dresel SH (2005) Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci 255:428–431PubMedCrossRefGoogle Scholar
  28. Lalonde R, Botez-Marquard T (1997) The neurobiological basis of movement initiation. Rev Neurosci 8:35–54PubMedGoogle Scholar
  29. Langley K, Marshall L, van den Bree M, Thomas H, Owen M, O’Donovan M, Thapar A (2004) Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry 161:133–138PubMedCrossRefGoogle Scholar
  30. Lijffijt M, Kenemans JL, Wal AT, Quik EH, Kemner C, Westenberg H, Verbaten MN, Engeland HV (2006) Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/hyperactivity disorder. Eur Psychiatr 21:544–547CrossRefGoogle Scholar
  31. Lin JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M (1992) Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591:319–326PubMedCrossRefGoogle Scholar
  32. Logan GD (1994) On the ability to inhibit thought and action. A users’ guide to the stop signal paradigm. In: Dagenbach D, Carr TH (eds) Inhibitory processes in attention, memory and language. Academic, San Diego, CA, pp 189–236Google Scholar
  33. Logan GD, Cowan WB (1984) On the ability to inhibit thought and action—a theory of an act of control. Psychol Rev 91:295–327CrossRefGoogle Scholar
  34. Overtoom CC, Verbaten MN, Kemner C, Kenemans JL, van Engeland H, Buitelaar JK, van der Molen MW, van der Gugten J, Westenberg H, Maes RA, Koelega HS (2003) Effects of methylphenidate, desipramine, and l-dopa on attention and inhibition in children with attention deficit hyperactivity disorder. Behav Brain Res 145:7–15PubMedCrossRefGoogle Scholar
  35. Pliszka SR (1989) Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 28:882–887PubMedCrossRefGoogle Scholar
  36. Randall DC, Shneerson JM, Plaha KK, File SE (2003) Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 18:163–173PubMedCrossRefGoogle Scholar
  37. Rapport MD, DuPaul GJ, Stoner G, Birmingham BK, Masse G (1985a) Attention deficit disorder with hyperactivity: differential effects of methylphenidate on impulsivity. Pediatrics 76:938–943PubMedGoogle Scholar
  38. Rapport MD, Stoner G, DuPaul GJ, Birmingham BK, Tucker S (1985b) Methylphenidate in hyperactive children: differential effects of dose on academic, learning, and social behavior. J Abnorm Child Psychol 13:227–243PubMedCrossRefGoogle Scholar
  39. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163:362–380CrossRefGoogle Scholar
  40. Robinson ESJ, Eagle DM, Banerjee G, Jiang X, Robbins TW (2006) Effects of atomoxetine on inhibitory control in the rat stop signal task. J Psychopharmacol 20:A67CrossRefGoogle Scholar
  41. Ross SB (1978) Antagonism by methylphenidate of the stereotyped behaviour produced by (+)-amphetamine in reserpinized rats. J Pharm Pharmacol 30:253–254PubMedGoogle Scholar
  42. Rugino TA, Copley TC (2001) Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. J Am Acad Child Adolesc Psychiatry 40:230–235PubMedCrossRefGoogle Scholar
  43. Rugino TA, Samsock TC (2003) Modafinil in children with attention-deficit hyperactivity disorder. Pediatr Neurol 29:136–142PubMedCrossRefGoogle Scholar
  44. Scheres A, Oosterlaan J, Swanson J, Morein-Zamir S, Meiran N, Schut H, Vlasveld L, Sergeant JA (2003) The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. J Abnorm Child Psychol 31:105–120PubMedCrossRefGoogle Scholar
  45. Schweitzer JB, Lee DO, Hanford RB, Tagamets MA, Hoffman JM, Grafton ST, Kilts CD (2003) A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response. Neuropsychopharmacology 28:967–973PubMedGoogle Scholar
  46. Semrud-Clikeman M, Filipek PA, Biederman J, Steingard R, Kennedy D, Renshaw P, Bekken K (1994) Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry 33:875–881PubMedCrossRefGoogle Scholar
  47. Sunohara GA, Voros JG, Malone MA, Taylor MJ (1997) Effects of methylphenidate in children with attention deficit hyperactivity disorder: a comparison of event-related potentials between medication responders and non-responders. Int J Psychophysiol 27:9–14PubMedCrossRefGoogle Scholar
  48. Sunohara GA, Malone MA, Rovet J, Humphries T, Roberts W, Taylor MJ (1999) Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence. Neuropsychopharmacology 21:218–228PubMedCrossRefGoogle Scholar
  49. Szabadi E (2006) Drugs for sleep disorders: mechanisms and therapeutic prospects. Br J Clin Pharmacol 61:761–766PubMedCrossRefGoogle Scholar
  50. Tanganelli S, Perez de la Mora M, Ferraro L, Mendez-Franco J, Beani L, Rambert FA, Fuxe K (1995) Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins. Eur J Pharmacol 273:63–71PubMedCrossRefGoogle Scholar
  51. Tannock R, Schachar RJ, Carr RP, Chajczyk D, Logan GD (1989) Effects of methylphenidate on inhibitory control in hyperactive-children. J Abnorm Child Psychol 17:473–491PubMedCrossRefGoogle Scholar
  52. Tannock R, Ickowicz A, Schachar R (1995) Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34:886–896PubMedCrossRefGoogle Scholar
  53. Taylor FB, Russo J (2000) Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol 10:311–320PubMedCrossRefGoogle Scholar
  54. Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M (1987) Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med 17:121–143PubMedCrossRefGoogle Scholar
  55. Turner D (2006) A review of the use of modafinil for attention-deficit hyperactivity disorder. Expert Rev Neurother 6:455–468PubMedCrossRefGoogle Scholar
  56. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 165:260–269PubMedGoogle Scholar
  57. Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ (2004) Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 55:1031–1040PubMedCrossRefGoogle Scholar
  58. van der Meere J, Shalev R, Borger N, Gross-Tsur V (1995) Sustained attention, activation and MPH in ADHD: a research note. J Child Psychol Psychiatry 36:697–703PubMedCrossRefGoogle Scholar
  59. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21:RC121PubMedGoogle Scholar
  60. Ward CP, Harsh JR, York KM, Stewart KL, McCoy JG (2004) Modafinil facilitates performance on a delayed nonmatching to position swim task in rats. Pharmacol Biochem Behav 78:735–741PubMedCrossRefGoogle Scholar
  61. Waters KA, Burnham KE, O’Connor D, Dawson GR, Dias R (2005) Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat. J Psychopharmacol 19:149–158PubMedCrossRefGoogle Scholar
  62. Zametkin AJ, Borcherding BG (1989) The neuropharmacology of attention-deficit hyperactivity disorder. Annu Rev Med 40:447–451PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Dawn M. Eagle
    • 1
  • Miles R. A. Tufft
    • 1
  • Hannah L. Goodchild
    • 1
  • Trevor W. Robbins
    • 1
  1. 1.Department of Experimental PsychologyUniversity of CambridgeCambridgeUK

Personalised recommendations